ReviewFrontiers in medical technology2026
IoMT-Fog-Cloud-based AI frameworks for chronic disease diagnosis: updated comparative analysis with recent AI-IoMT models (2020-2025).
Review in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robust Non-Invasive Cardiac Index Prediction via Feature Integration and Data-Augmented Neural Networks.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic diseases such as diabetes and cardiovascular disease require frequent monitoring and timely clinical feedback to prevent complications. Internet of Medical Things (IoMT) systems increasingly combine near-patient sensing with Fog and Cloud computing so that time-critical preprocessing and inference can run close to the patient while compute-intensive training and population-level analytics remain in the Cloud. This review synthesizes primary studies published between 2020 and 2025 that implement AI-enabled IoMT, with an emphasis on systems that report both diagnostic performance and network quality-of-service (QoS). Following PRISMA 2020, we screened database records and included 14 primary studies; we focus the joint performance-QoS synthesis on six IoMT-Fog-Cloud frameworks for diabetes and cardiovascular disease and compare them with two recent multi-disease AI-IoMT models (DACL and TasLA). Diabetes-oriented implementations commonly report accuracy around 95%-96% using explainable or ensemble deep learning, whereas some cardiovascular frameworks report >99% accuracy in controlled settings; we therefore discuss plausible sources of optimistic performance, including small datasets, class imbalance, curated benchmarks, and potential leakage/overfitting in simulation-based evaluations. Across IoMT-Fog-Cloud studies, placing preprocessing and/or inference at the Fog layer repeatedly reduces end-to-end latency for streaming biosignals, but multi-Fog provisioning can increase energy and power demands. To support more reproducible comparisons, we organize 14 extracted metrics into (i) diagnostic performance (accuracy, precision, recall, F1-score, sensitivity, specificity) and (ii) system/network QoS (latency, jitter, throughput, bandwidth utilization, processing/execution time, network usage, energy consumption, power consumption), and we translate the evidence into study-linked design recommendations for future deployments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.